Skip to main content
OpenTrials
Completed

NCT Number: NCT05781737

Inflammatory Bowel Disease and Atherosclerosis Development

The study will show the influence of inflammatory bowel disease on the risk of development of atherosclerosis

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Inflammatory Bowel Diseases Arterial Stiffness Cardiovascular Diseases Digestive System Diseases Gastroenteritis Gastrointestinal Diseases Inflammation Intestinal Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital #1

Moscow, 119991, Russia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Inflammatory bowel disease
  • Signed informed consent

Exclusion criteria

  • Pregnancy
  • Other conditions affecting the prognosis
  • Psychiatric disorders affecting the participation in the study

Treatment and study plan

Primary outcomes

  1. Intima-media thickness

    Time frame: 1 year

    Intima-media thickness

  2. Pulse wave velocity

    Time frame: 1 year

    Pulse wave velocity

Secondary outcomes

  1. All cause mortality

    Time frame: 1 year

  2. Cardiovascular mortality

    Time frame: 1 year

  3. Hospitalisation due to cardiovascular disease

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

I.M. Sechenov First Moscow State Medical University

Other

Registry information

Important dates

Study start
2022
Primary completion
2024
Study completion
2025
First posted
Mar 23, 2023
Registry last updated
May 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.